MX9604966A - Derivados de tropano-2-aldoxina como inhibidores de reabsorcion de neurotransmisores. - Google Patents

Derivados de tropano-2-aldoxina como inhibidores de reabsorcion de neurotransmisores.

Info

Publication number
MX9604966A
MX9604966A MX9604966A MX9604966A MX9604966A MX 9604966 A MX9604966 A MX 9604966A MX 9604966 A MX9604966 A MX 9604966A MX 9604966 A MX9604966 A MX 9604966A MX 9604966 A MX9604966 A MX 9604966A
Authority
MX
Mexico
Prior art keywords
cycloalkyl
alkyl
alkynyl
alkenyl
substituted
Prior art date
Application number
MX9604966A
Other languages
English (en)
Other versions
MXPA96004966A (es
Inventor
Peter Moldt
Frank Waetjen
Jorgen Scheel-Krueger
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of MX9604966A publication Critical patent/MX9604966A/es
Publication of MXPA96004966A publication Critical patent/MXPA96004966A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invencion se refiere a compuesto de la formula (I), (II), (III) o (IV) y cualquier mezcla de los mismos, o una sal farmacéuticamente aceptable de los mismos; en donde R es hidrogeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquilalquilo arilo o alquilo de los cuales todos pueden ser sustituidos con COOH, COO-alquilo, COO-cicloalquilo, o fenilo que puede ser substituido una o más veces son substitutos seleccionados a partir del grupo que consiste de halogeno, CF3, CN, alcoxi, cicloalcoxi, alquilo, cicloalquilo, alquenilo, alquinilo, amino, nitro; y R4 es fenilo que puede ser sustituido una o más veces con substitutos seleccionados a partir del grupo que consiste de halogeno, CF3, CN, alcoxi, cicloalcoxi, alquilo, cicloalquilo, alqueniloalquinilo, amino, nitro, heteroarilo, y arilo; 3, 4-metilendiodisoxifenilo; bencilo que puede ser sustituido una o más veces con substitutos seleccionados a partir del grupo que consiste de halogeno, CF3, CN, alcoxi, cicloalcoxi, alquilo, cicloalquilo, alquenilo, alquinilo, amino, nitro, heteroarilo y arilo; heteroarilo que puede ser sustituido una o más veces con substitutos seleccionados a partir del grupo que consiste de halogeno, CF3, CN, alcoxi, cicloalcoxi, alquilo, cicloalquilo, alquenilo, alquinilo, amino, nitro, heteroarilo y arilo; o naftilo que puede ser substituido una o más veces con substitutos seleccionados a partir del grupo que consiste de halogeno, CF3, CN, alcoxi, cicloalcoxi, alquilo, cicloalquilo, alquenilo, alquinilo, amino, nitro, heteroarilo y arilo; los compuestos poseen propiedades farmacéuticas de valor como transmisores de monoamina, es decir, inhibidores de reabsorcion de dopamina, serotonina, noradrenalina.
MXPA/A/1996/004966A 1994-04-19 1995-01-12 Derivados de tropano-2-aldoxina como inhibidoresde reabsorcion de neurotransmisores MXPA96004966A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK0447/94 1994-04-19
DK133894 1994-11-24
DK1338/94 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (2)

Publication Number Publication Date
MX9604966A true MX9604966A (es) 1998-05-31
MXPA96004966A MXPA96004966A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
CZ284379B6 (cs) 1998-11-11
ATE222587T1 (de) 2002-09-15
EE9600132A (et) 1997-04-15
EP0756596A1 (en) 1997-02-05
DE69527839T2 (de) 2003-01-02
NO964180D0 (no) 1996-10-02
EE03877B1 (et) 2002-10-15
SK128896A3 (en) 1997-04-09
AU690257B2 (en) 1998-04-23
PL183025B1 (pl) 2002-05-31
LV11738B (en) 1997-12-20
BR9507489A (pt) 1997-08-12
FI965074A0 (fi) 1996-12-17
US5736556A (en) 1998-04-07
RU2134264C1 (ru) 1999-08-10
EP0756596B1 (en) 2002-08-21
HU215830B (hu) 2001-05-28
DE69527839D1 (en) 2002-09-26
KR100210417B1 (ko) 1999-07-15
GEP19991749B (en) 1999-09-10
BG100883A (en) 1998-03-31
CA2187309A1 (en) 1995-10-26
BG63259B1 (bg) 2001-07-31
UA49801C2 (uk) 2002-10-15
HUT75865A (en) 1997-05-28
DK0756596T3 (da) 2002-12-23
FI965074A (fi) 1996-12-17
WO1995028401A1 (en) 1995-10-26
AU2257595A (en) 1995-11-10
CN1148854A (zh) 1997-04-30
NO964180L (no) 1996-12-16
NZ284075A (en) 1998-01-26
CZ298296A3 (en) 1997-06-11
CN1043763C (zh) 1999-06-23
SK280875B6 (sk) 2000-08-14
PL316876A1 (en) 1997-02-17
HU9602707D0 (en) 1996-11-28
JPH09505607A (ja) 1997-06-03
JP2899418B2 (ja) 1999-06-02
CA2187309C (en) 2000-11-21
LV11738A (lv) 1997-04-20

Similar Documents

Publication Publication Date Title
UA49872C2 (uk) Похідні тропану, спосіб їх одержання, фармацевтична композиція та спосіб лікування
NO980919D0 (no) 8-azabicyklo(3.2.1)okt-2-ene derivater, deres fremstilling og anvendelse
UA49801C2 (uk) Похідні тропан-2-альдоксиму, спосіб їх отримання, фармацевтична композиція, спосіб лікування
MY114679A (en) Aroyl-piperidine derivatives
AU7563196A (en) Fused tropane-derivatives as neurotransmitter reuptake inhibitors
ES2141688A1 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
AU7206398A (en) Piperidine derivatives as neurotransmitter re-uptake inhibitors
HUP0000315A2 (hu) Heterociklusos szubsztituált pirrolidin-amid származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees